Precision BioSciences (DTIL) Tops Q4 EPS by 105c
Tweet
Share
E-mailGet Alerts DTIL Hot Sheet
Join SI Premium – FREE
Precision BioSciences (NASDAQ: DTIL) reported Q4 EPS of $1.05. Revenue for the quarter came in at $34 million.
For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Cloudastructure reports 164% subscription revenue growth in Q2 2026
- Evaxion adds brain cancer vaccine program, drops EVX-03
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
